• HÁGASE MIEMBRO
    Obtenga acceso total a theheart.org
    Siendo miembro usted podrá ver nuestros videos educativos y editoriales, realizar búsquedas en nuestro sitio web, descargar diapositivas, participar en discusiones, recibir nuestros boletines de noticias y mucho más.

    ¡Asociarse es gratuito!
    ¡Acceso sin restricciones!
    benefíciese de 30 días de acceso limitado gratuito para leer las noticias de heartwire
    Profesional de la salud   Si No
    ¡Acceso limitado!

Resource Center

Supported by an independent educational grant from Daiichi Sankyo, Inc.

What's New
Abstract
Abstracts
Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
Drummond W, Sirenko YM, Ramos E, et al. Am J Cardiovasc Drugs. 2011;11:327-333.
Abstract
Abstracts
Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a subpopulation analysis of the TRINITY study.
Chrysant SG, Izzo JL Jr, Kereiakes DJ, et al. J Am Soc Hypertens. 2011. [Epub ahead of print]
Abstract
Abstracts
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
Piller LB, Baraniuk S, Simpson LM, et al. Circulation. 2011;124:1811-1818.
Abstract
Abstracts
Nondrug interventions for treatment of hypertension.
Woolf KJ, Bisognano JD. J Clin Hypertens (Greenwich). 2011;13:829-835.
Abstract
Abstracts
Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States.
Deshmukh A, Kumar G, Kumar N, et al. Am J Cardiol. 2011;108:1277-1282.
Abstract
Abstracts
Treatment of kidney transplant recipients with ACEi/ARB and risk of respiratory tract cancer: a collaborative transplant study report.
Opelz G, Döhler B. Am J Transplant. 2011;11:2483-2489.
Abstract
Abstracts
Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.
Yoon C, Yang HS, Jeon I, et al. CMAJ. 2011;183:E1073-1084.
Abstract
Abstracts
Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension.
Ukena C, Mahfoud F, Kindermann I, et al. J Am Coll Cardiol. 2011;58:1176-1182.
Abstract
Abstracts
Restless legs syndrome and hypertension in middle-aged women.
Batool-Anwar S, Malhotra A, Forman J, Winkelman J, Li Y, Gao X. Hypertension. 2011;58:791-796.
Abstract
Abstracts
Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study).
Gray L, Lee IM, Sesso HD, et al. J Am Coll Cardiol. 2011;58:2396-2403.